⌘K

Nutriband Inc. (NTRB)

$5.60 10.24% $0.52 Healthcare

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Market cap

$62.14M

CEO

Mr. Gareth Sheridan

Full time employees

13.00

Headquarters

Orlando, FL

IPO Date

Nov 30, 2017

Price-to-earnings (PE) Ratio

-6.91

Earnings-per-share (EPS)

$-0.81

Cash ratio (TTM)

6.13

Current ratio (TTM)

6.57

Net profit margin (TTM)

-401.62%

PE ratio (TTM)

-8.58

PEG ratio (TTM)

-0.17

Price-to-book ratio (TTM)

4.99

Price-to-sales ratio (TTM)

34.57

Quick ratio (TTM)

6.36

Return on assets (TTM)

-53.14%

Return on equity (TTM)

-76.31%

Similar stocks (13)

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76% $0.30

Uptrend

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

MediciNova, Inc.

MNOV

$1.69 9.03% $0.14

Neutral

Champions Oncology, Inc.

CSBR

$4.89 14.25% $0.61

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.08 4.00% $0.08

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00% $0.00

Downtrend

Longeveron Inc.

LGVN

$2.06 0.49% $0.01

Downtrend

RenovoRx, Inc.

RNXT

$0.98 -0.61% $-0.00

Downtrend

HCW Biologics Inc.

HCWB

$0.50 -16.65% $-0.10

Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.50 6.38% $0.09

Downtrend

Forte Biosciences, Inc.

FBRX

$7.00 4.09% $0.28

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.58 -0.84% $-0.00

Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00% $0.00

Downtrend

ETF Exposure (5)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Neutral

Similar stocks (13)

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76% $0.30

Uptrend

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

MediciNova, Inc.

MNOV

$1.69 9.03% $0.14

Neutral

Champions Oncology, Inc.

CSBR

$4.89 14.25% $0.61

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.08 4.00% $0.08

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00% $0.00

Downtrend

Longeveron Inc.

LGVN

$2.06 0.49% $0.01

Downtrend

RenovoRx, Inc.

RNXT

$0.98 -0.61% $-0.00

Downtrend

HCW Biologics Inc.

HCWB

$0.50 -16.65% $-0.10

Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.50 6.38% $0.09

Downtrend

Forte Biosciences, Inc.

FBRX

$7.00 4.09% $0.28

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.58 -0.84% $-0.00

Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00% $0.00

Downtrend

ETF Exposure (5)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend